Science & Co Review: Who Handles Your GLP-1 Care, Prescription and Delivery?

An online questionnaire may be the front door to Science & Co, but the company behind that screen is not necessarily the organization treating you or dispensing your medicine. Science and Co, Inc. describes itself as a technology and administrative platform connecting patients with independent clinicians and pharmacies. For someone considering its GLP-1 offerings, the central question is therefore not just what appears in the catalog, but who takes responsibility at each step after enrollment.

This review follows that pathway: assessment, prescribing, product selection, pharmacy fulfillment, delivery and continuing care. Public documentation consulted October 19, 2026 describes a five-minute intake, most clinical reviews within 24–48 hours, free shipping and ongoing messaging. It also advertises low monthly prices tied to 12-month plans without explaining the initial collection amount. The service has a documented care framework, but several practical details still need confirmation before payment or a first shipment.

At a glance

Platform, not the treating practice: Science & Co says independent professional entities provide healthcare and independent pharmacies dispense prescriptions.
Sources: [10]
Advertised reach: Services are offered to adults 18 and older located in the United States, across all 50 states and Washington, DC; prescribing remains conditional on consultation.
Sources: [10]
Review versus delivery: Most clinical reviews are advertised as taking 24–48 hours. That is not a promised medication arrival time.
Sources: [12]
Conditional starting prices: Compounded injectable semaglutide starts at $59 per month and compounded injectable tirzepatide at $99 per month on 12-month plans; initial collection amounts are not established.
Sources: [12] [13]
Cancellation deadline: Pause or cancel at least 72 hours before the next scheduled processing date. Cancellation does not reverse orders already prescribed, dispensed or shipped.
Sources: [12] [7]

Start by separating the platform from the care team

Science and Co, Inc., identified in its terms as a Delaware corporation, operates the online platform. It explicitly says it does not provide medical advice, diagnosis or treatment and does not dispense medication. Those responsibilities sit with professional entities and their licensed healthcare professionals, and with independent pharmacies. That distinction matters when asking who can answer a clinical question, change a prescription or resolve a dispensing problem.

The terms advertise service across all 50 states and the District of Columbia, only for people located within the United States. Users must be at least 18. Science & Co also says each prescription comes from a provider licensed in the patient’s state. These are provider representations, not independently verified licenses or proof that every catalog option will be available to every adult who applies.

The consulted documentation does not identify the professional entities, individual prescribers or dispensing pharmacies that would serve a particular patient. Before proceeding, request those names and the contact route for each organization. Our guide to clinicians and telehealth platforms explains why a single branded website can involve several separate responsibilities. Knowing the actual parties is more useful than assuming the Science & Co name covers every part of care.

Sources: [10] [12]

What happens between the questionnaire and a prescription

Science & Co describes its opening questionnaire as entirely online, taking about five minutes and carrying no initial commitment. The illustrated intake asks about previous GLP-1 use, type 2 diabetes, thyroid history, and pregnancy or nursing. These questions show some of the information being collected; they do not establish a complete set of exclusion rules. The public documentation also does not settle whether routine laboratory testing is required.

A licensed provider then reviews the answers, with most reviews advertised as complete within 24–48 hours. The terms impose three conditions before a prescription product can be provided: completion of a platform consultation, a provider’s determination that the product is appropriate, and an issued prescription. Submitting a questionnaire is therefore not a prescription guarantee, and the review estimate is not a shipping or delivery promise.

The materials do not establish whether every patient has a live video appointment, a telephone conversation or another consultation format. They also do not publish complete BMI criteria or clarify whether any requested laboratory work is included in the plan price. A practical next step is to ask what additional records, conversations or tests might be needed before approval. The first-consultation preparation guide can help organize questions without treating the website’s intake as individualized medical advice.

Sources: [12] [10]

The catalog requires a product-by-product check

The documented injectable offerings include compounded semaglutide, compounded tirzepatide, branded Zepbound identified as tirzepatide from Eli Lilly, and branded Wegovy identified as semaglutide from Novo Nordisk. Another listing, “Personalized GLP-1 & GIP-1,” describes a weekly injection without identifying its precise active ingredient in the cited heading. That is an important distinction: a pathway label is not enough to establish what a patient would actually receive.

The catalog also advertises Wegovy semaglutide tablets and Foundayo orforglipron tablets. Science & Co describes these as branded daily products, manufactured by Novo Nordisk and Eli Lilly respectively, dispensed sealed and unaltered, and FDA approved. Those are the provider’s claims, not independent product-verification findings in this review. Some branded pages also repeat generic wording about medicine being made by a US pharmacy, so request the exact product and manufacturer rather than relying on a shared promotional block.

A GLP-1/GIP-1 Microdose injection is marked “Coming Soon” on its specific page, despite conflicting catalog labeling; availability is not confirmed. NAD+ and sermorelin injections appear separately under longevity. None of these catalog entries establishes individual suitability. For any proposed prescription, confirm the active ingredient, route, presentation and whether it is compounded or a manufacturer’s branded product before evaluating its price or expected fulfillment.

Sources: [12] [13] [14] [5] [8] [9] [11] [6] [4]

The pharmacy handoff is documented, but the pharmacy is not named

Science & Co says it works only with state-licensed US compounding pharmacies, that every batch undergoes third-party purity and potency testing, and that patients can request a Certificate of Analysis for their prescription. These are useful questions to pursue with the actual dispensing pharmacy, but the statements are not independent verification of a particular batch. The terms also allow an issued prescription to be sent to a pharmacy the patient chooses.

That pharmacy-choice provision does not explain how an outside pharmacy would affect the bundled price, shipping, included supplies or follow-up arrangements. Ask for those consequences before requesting a transfer. Our pharmacy-handoff guide sets out the distinction between prescribing and dispensing. For branded products, dispensing does not mean the pharmacy manufactured the medicine; for compounded products, the precise preparation and dispensing source still need to be identified.

Science & Co discloses that compounded preparations are not FDA approved or evaluated by FDA for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence. FDA also reports measurement and administration errors involving compounded medication, making clear instructions from the prescriber or pharmacist important; this review does not provide dosing instructions.

Sources: [12] [10] [1]

Delivery promises stop short of a complete shipping policy

The product pages advertise free home shipping and medication arriving on a monthly schedule. They also say plans include supplies. That describes the intended service rhythm, not a documented carrier schedule or transit guarantee. The consulted materials do not specify preparation time, dispatch timing, carriers, cold-chain procedures or how tracking is communicated. A 24–48-hour clinical review should not be used to estimate when a package will reach the door.

The content of Shipping & Returns was not consulted, so this review cannot establish a complete replacement or refund process for loss, damage or temperature problems. Before a first shipment, ask which organization handles those reports, what evidence it requests and how an interrupted shipment affects continuing care. The terms additionally warn that medicines may not arrive in child-resistant containers, a packaging detail worth clarifying before delivery.

FDA explicitly advises not using an injectable GLP-1 product that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy to resolve the concern. That guidance is not a finding about Science & Co’s shipping performance. It is a practical boundary for an unresolved delivery problem. The guide to warm injectable deliveries explains the FDA advice separately from any provider’s commercial shipping promises.

Sources: [12] [10] [1]

Ongoing care includes messaging, with limits on what is promised

The advertised plan includes an assessment reviewed by a licensed provider, secure messaging, scheduled check-ins, ongoing clinical monitoring and treatment adjustments when clinically appropriate. The FAQ says the same provider stays with the patient month to month. That continuity claim is more specific than a general promise of access to a rotating care team, although the documentation does not explain substitutions, provider absences or how continuity would be maintained after a staffing change.

Science & Co advertises “24/7 support,” explaining that patients can message their care team at any time. It does not publish a guaranteed response interval or establish round-the-clock live clinician availability. Follow-up frequency is also not fully settled: the homepage refers to monthly check-ins, while an illustrative interface describes weekly check-ins during the first eight weeks. Neither should be treated as a single, clearly established contractual schedule for every patient.

The contact page calls an account message the fastest route for existing members. Email is available at support@science.co, and the terms list 1 (844) 587-5747. Availability of Spanish-language care is not established. The site expressly excludes medical emergencies and directs users to 911 or an emergency room. NIDDK’s broader guidance emphasizes that follow-up concerns response and tolerability, not simply continued payments; ask who reviews those issues between scheduled contacts.

Sources: [12] [7] [3] [10] [4] [2]

What the advertised payment buys—and what checkout must resolve

Science & Co’s lowest documented prices attach to 12-month plans, not clearly established month-to-month arrangements. Compounded injectable semaglutide starts at $59 per month and compounded injectable tirzepatide at $99 per month. Both pages advertise the same price across doses, no monthly membership fee and free shipping. The personalized GLP-1/GIP-1 injection also starts at $59 per month on a 12-month plan, but its exact composition is not established.

The semaglutide header displays a $149 reference price and claims 60% savings; the tirzepatide header displays $199 and claims 50% savings. Separately, the homepage promotes 20% off the first month and a free online provider evaluation. The documentation does not explain whether those promotions combine. It also does not establish an introductory-to-renewal price sequence, initial collection amount, payment schedule for the 12-month offers or financial adjustment after early cancellation.

The terms say subscription totals include pharmacy charges, professional services and applicable platform fees, with automatic charges at the recurring intervals disclosed during checkout. The FAQ describes cash payment and generally HSA/FSA-eligible treatment, with itemized receipts available; that is not an individual eligibility determination. More importantly, the terms prohibit seeking reimbursement from federal, state or private healthcare payors for these services or products, going beyond a simple statement that the platform does not bill insurance.

Documented prices and the conditions that matter before payment
Offering	Published price or promotion	Important condition or gap
Compounded semaglutide injection	Starting at $59 per month	12-month plan; same price across doses; initial collection not established
Compounded tirzepatide injection	Starting at $99 per month	12-month plan; same price across doses; initial collection not established
Personalized GLP-1 & GIP-1 injection	Starting at $59 per month	12-month plan; precise active ingredient not established
Homepage promotion	20% off first month; free online provider evaluation	Combination with 12-month offers not explained
Branded injections and tablets	No concrete prices established in consulted pages	Request product-specific price and billing terms

Sources: [12] [13] [14] [4] [7] [10]

Cancellation needs to be coordinated with the next order

The product page says there is no lock-in and no cancellation fee, with pausing or cancellation available through the account. The FAQ also accepts requests at support@science.co. Both place the deadline at least 72 hours before the next scheduled processing date. That date matters more than a general monthly anniversary: patients should identify it explicitly and retain confirmation that a pause or cancellation has been recorded.

Cancellation stops future orders but does not reverse an order already prescribed, dispensed or shipped. It therefore does not establish a refund entitlement for work or medication already processed. The documentation leaves unresolved how the no-lock-in claim interacts financially with a discounted 12-month plan. A 12-month price label alone establishes neither the quantity shipped at once nor a minimum commitment, and it does not prove that a full year must be prepaid.

Before enrollment, obtain the actual checkout charge, renewal interval, next processing date and written explanation of early cancellation. Also ask what happens if a clinician changes the treatment plan, declines further prescribing or requests additional evaluation. The consulted documentation does not provide a complete refund policy or explain every such scenario. Those answers are part of understanding the care arrangement, not merely an administrative detail to address after an unwanted charge.

Sources: [12] [13] [10] [7]

Questions & answers

Does Science & Co itself prescribe and dispense the medication?

Its terms say no. Science & Co operates the platform; professional entities and their licensed clinicians provide medical care, while independent pharmacies dispense medication. The product pages say prescriptions are written by providers licensed in the patient’s state. Ask for the treating practice, prescriber and dispensing pharmacy names, because the consulted documentation does not identify who would handle an individual patient’s care.

Sources: [10] [12]

Can I expect medication within 24–48 hours?

No delivery promise is established by that estimate. Science & Co says most clinical reviews take 24–48 hours. Prescribing, pharmacy preparation, dispatch and transit are separate steps. Although the service advertises free monthly home delivery, the consulted documentation does not specify transit times or carriers. Ask for an estimated first-shipment schedule after the clinical review rather than treating approval as arrival.

Sources: [12]

Is the $59 semaglutide offer an ordinary monthly subscription?

The documented $59-per-month starting price is specifically for compounded injectable semaglutide on a 12-month plan. The page also advertises the same price across doses, no monthly membership fee and free shipping. It does not establish the initial amount collected or whether that plan is paid monthly or another way. Request those details and the consequences of early cancellation before authorizing payment.

Sources: [12] [10]

Can I use my own pharmacy or seek insurance reimbursement?

The terms allow an issued prescription to be sent to a pharmacy of your choice, but do not explain how outside fulfillment changes the package price or included services. Insurance is a separate restriction: the FAQ describes cash payment, and the terms prohibit seeking reimbursement from federal, state or private healthcare payors for products or services obtained through the platform. Do not assume an itemized receipt overrides that provision.

Sources: [10] [7]

Does 24/7 support mean immediate access to a clinician?

The documented promise is that patients can message the care team at any time, not that a clinician will respond immediately. No guaranteed response interval is published. Existing members are directed to account messaging as the fastest route, with email and telephone also listed. The service is not for emergencies; its contact page directs medical emergencies to 911 or the nearest emergency room.

Sources: [12] [3] [10]

Will cancellation refund an order that is already underway?

The cancellation language does not promise that. It says cancellation stops future orders and does not reverse an order already prescribed, dispensed or shipped. Pause or cancel at least 72 hours before the next scheduled processing date, through the account or support email. A complete refund and replacement policy was not established in the consulted documentation, so obtain the applicable terms rather than equating no cancellation fee with a refund.

Sources: [12] [7]

Our assessment

Science & Co documents a recognizable telehealth pathway: online intake, conditional prescribing by independent clinicians, pharmacy fulfillment, home shipping and continuing messaging. Its stated inclusions, pharmacy-choice provision and cancellation deadline give prospective patients useful starting points. The limitations are concentrated at the handoffs: the actual treating and dispensing organizations are unnamed, shipping and replacement procedures are incomplete, and support availability is not a response-time guarantee. The largest financial uncertainty is how discounted 12-month pricing works alongside the no-lock-in claim. Before enrolling, obtain the exact product, responsible practice and pharmacy, first charge, billing interval, next processing date and applicable refund terms in writing. That information would make the advertised pathway substantially easier to evaluate without mistaking a broad service promise for a fully specified care arrangement.

Visit Science & Co’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Science & Co Review: Who Handles Your GLP-1 Care, Prescription and Delivery?

At a glance

01Start by separating the platform from the care team

02What happens between the questionnaire and a prescription

03The catalog requires a product-by-product check

04The pharmacy handoff is documented, but the pharmacy is not named

05Delivery promises stop short of a complete shipping policy

06Ongoing care includes messaging, with limits on what is promised

07What the advertised payment buys—and what checkout must resolve

08Cancellation needs to be coordinated with the next order